WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 430  429  428  426  425  408  375  330 
Births
Surviving infants
Pop. less than 5 years 20  20  21  21  20  24  32  30 
Pop. less than 15 years 62  63  64  66  66  85  93  77 
Female 15-49 years 97  98  98  99  99  104  98  94 

Number of reported case

(Click for retrospective incidence data for Malta)
Diphtheria
Japanese encephalitis
Measles 14 
Mumps 386 
Pertussis 106 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Malta)
Vaccine year result method % card seen                                                
BCG          92  93  84  77 
DTP1          100  100  100  100  97  97 
DTP3          99  99  99  96  76  94  63 
HepB_BD         
HepB3          90  94  93  82  75 
Hib3          99  99  99  96  76  93 
JapEnc         
MCV          98  99  93  84  73  74  80 
MCV2          94  88  91  85  97 
PCV1         
PCV3         
Pol3          99  99  99  96  76  94  86 
Rota1         
Rota_last         
Rubella1          98  84  73  93 
TT2plus          86 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Malta)
BCG 77 
DTP1 99  99  99  97  97  84 
DTP3 99  99  96  76  94  63 
HepB3 94  93  82  75 
HepB_BD
Hib3 99  99  96  76  93 
MCV 99  93  84  73  74  80 
MCV2 88  91  85  85 
PCV3
Pol3 99  99  96  76  94  86 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes Babies of parents from high risk countries
DTaPHibIPV 6 weeks; 3, 4, 18 months; Yes
HPV 12 years; +1, +6 months; Yes
HepB_Pediatric 12, 13, 18 months; Yes
Influenza_Adult > 55 years; Yes and health care workers, adults with chronic diseases and other risk groups
Influenza_Pediatric < 5 years; Yes and children with chronic diseases
MMR 13 months; 4 years; Yes
TdIPV 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     2012-2015  2011-2013  2010-2012  2010-2014   
Nº of districts with microplans that include activities to raise immunization coverage number     NA     

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100     
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%        

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  NA  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100          100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.